QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
NASDAQ:JAGX

Jaguar Health (JAGX) Stock Forecast, Price & News

$0.66
-0.01 (-1.50%)
(As of 06/8/2023 ET)
Compare
Today's Range
$0.64
$0.68
50-Day Range
$0.48
$0.98
52-Week Range
$0.46
$28.50
Volume
369,963 shs
Average Volume
2.29 million shs
Market Capitalization
$9.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

JAGX stock logo

About Jaguar Health (NASDAQ:JAGX) Stock

Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer, which is in Phase 3 clinical trial for or prophylaxis of diarrhea in adult cancer patients, and to address rare/orphan disease indications, including Short bowel syndrome with intestinal failure and/or congenital diarrheal disorders; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops NP-300, a second-generation proprietary anti-secretory antidiarrheal drug for symptomatic relief and treatment of moderate-to-severe diarrhea; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. The company was founded in 2013 and is headquartered in San Francisco, California.

Receive JAGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jaguar Health and its competitors with MarketBeat's FREE daily newsletter.

JAGX Stock News Headlines

Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
StockNews.com Upgrades Jaguar Health (NASDAQ:JAGX) to Hold
Q1 2023 Jaguar Health Inc Earnings Call
Jaguar Health (NASDAQ:JAGX) Upgraded at StockNews.com
8-K: Jaguar Health, Inc.
StockNews.com Lowers Jaguar Health (NASDAQ:JAGX) to Sell
See More Headlines

JAGX Price History

JAGX Company Calendar

Last Earnings
11/17/2021
Today
6/08/2023
Next Earnings (Estimated)
8/28/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:JAGX
Fax
N/A
Employees
60
Year Founded
N/A

Profitability

Net Income
$-47,450,000.00
Net Margins
-368.66%
Pretax Margin
-377.14%

Debt

Sales & Book Value

Annual Sales
$11.96 million
Book Value
($0.32) per share

Miscellaneous

Free Float
13,840,000
Market Cap
$9.25 million
Optionable
Not Optionable
Beta
1.82

Key Executives

  • Ms. Lisa A. Conte (Age 64)
    Founder, CEO, Pres & Director
    Comp: $771.4k
  • Dr. Pravin R. Chaturvedi Ph.D. (Age 60)
    Chief Scientific Officer & Chair of Scientific Advisory Board
    Comp: $539.04k
  • Mr. Jonathan S. Wolin CPA (Age 60)
    J.D., M.B.A., Chief of Staff, Chief Compliance Officer & Gen. Counsel
    Comp: $520.29k
  • Mr. Ian H. Wendt M.B.A. (Age 55)
    Chief Commercial Officer
    Comp: $441.31k
  • Dr. Steven R. King Ph.D. (Age 65)
    Chief of Sustainable Supply, Ethnobotanical Research & Intellectual Property and Sec.
    Comp: $477.66k
  • Ms. Carol R. Lizak M.B.A. (Age 59)
    Chief Financial Officer
  • Mr. Peter Hodge
    Sr. Director of Investor Relations, Bus. Devel. & Special Events
  • Dr. Karen J. Brunke Ph.D. (Age 70)
    Exec. VP of Corp. & Bus. Devel.
  • Mr. David Sesin
    Chief Manufacturing Officer













JAGX Stock - Frequently Asked Questions

How have JAGX shares performed in 2023?

Jaguar Health's stock was trading at $0.0869 on January 1st, 2023. Since then, JAGX stock has increased by 668.1% and is now trading at $0.6675.
View the best growth stocks for 2023 here
.

Are investors shorting Jaguar Health?

Jaguar Health saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 2,950,000 shares, an increase of 163.4% from the April 30th total of 1,120,000 shares. Based on an average daily volume of 3,550,000 shares, the short-interest ratio is presently 0.8 days.
View Jaguar Health's Short Interest
.

When is Jaguar Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 28th 2023.
View our JAGX earnings forecast
.

How were Jaguar Health's earnings last quarter?

Jaguar Health, Inc. (NASDAQ:JAGX) issued its quarterly earnings results on Wednesday, November, 17th. The biotechnology company reported ($0.27) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.18) by $0.09. The biotechnology company had revenue of $0.63 million for the quarter. Jaguar Health had a negative trailing twelve-month return on equity of 1,337.16% and a negative net margin of 368.66%. During the same quarter last year, the business posted ($0.63) earnings per share.

When did Jaguar Health's stock split?

Jaguar Health shares reverse split before market open on Wednesday, September 8th 2021. The 1-3 reverse split was announced on Wednesday, September 8th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, September 8th 2021. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

What other stocks do shareholders of Jaguar Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Jaguar Health investors own include Biocept (BIOC), Sorrento Therapeutics (SRNE), Trevena (TRVN), Vaxart (VXRT), Purple Biotech (KTOV), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Biopharmx (BPMX), Cara Therapeutics (CARA) and Conatus Pharmaceuticals (CNAT).

When did Jaguar Health IPO?

(JAGX) raised $22 million in an IPO on Wednesday, May 13th 2015. The company issued 3,200,000 shares at $7.00 per share. Aegis Capital Corp acted as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers.

What is Jaguar Health's stock symbol?

Jaguar Health trades on the NASDAQ under the ticker symbol "JAGX."

Who are Jaguar Health's major shareholders?

Jaguar Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Acadian Asset Management LLC (0.50%), Two Sigma Securities LLC (0.37%), BlackRock Inc. (0.37%) and Simplex Trading LLC (0.00%).
View institutional ownership trends
.

How do I buy shares of Jaguar Health?

Shares of JAGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Jaguar Health's stock price today?

One share of JAGX stock can currently be purchased for approximately $0.67.

How much money does Jaguar Health make?

Jaguar Health (NASDAQ:JAGX) has a market capitalization of $9.25 million and generates $11.96 million in revenue each year.

How can I contact Jaguar Health?

Jaguar Health's mailing address is 201 MISSION STREET SUITE 2375, SAN FRANCISCO CA, 94105. The official website for the company is www.jaguaranimalhealth.com. The biotechnology company can be reached via phone at (415) 371-8300.

This page (NASDAQ:JAGX) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -